Gregory A. Razka v. HHS - Tdap, Guillain-Barré Syndrome (2017)

Filed 2014-12-22Decided 2017-05-15Vaccine Tdap
compensated$90,000

Case summary [AI summaries can sometimes make mistakes]

Gregory A. Razka filed a petition for compensation under the National Vaccine Injury Compensation Program on December 22, 2014, alleging that he suffered from Guillain-Barré Syndrome (GBS) as a result of receiving a Tetanus-Diphtheria-Acellular Pertussis (Tdap) vaccination on May 25, 2013.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr. Razka's alleged GBS or any other injury.

Despite the denial, the parties reached a settlement agreement. The joint stipulation, filed on April 20, 2017, outlined the terms of the settlement.

As part of the agreement, the respondent agreed to issue a lump sum payment of $90,000.00 to Mr. Razka, intended to compensate for all damages available under the program.

The Special Master adopted the stipulation and directed that judgment be entered in accordance with the decision. The decision date was May 15, 2017.

Source PDFs 2 total · 1 downloaded